Search Results - "Magbanua, MJM"

Abstract P4-01-12: Low peripheral blood CD4/CD8 ratio at the time of surgery is a negative long-term prognostic factor in women with early stage breast cancer by Magbanua, MJM, Yau, C, Scott, JH, van't Veer, L, Park, JW, Esserman, L, Campbell, M

“…Abstract It is hypothesized that cancer prognosis may be related to the functional status of the immune system. We examined the correlation between peripheral…”
Get full text

Abstract P3-01-02: Detection of circulating tumor cells (CTC) in blood and disseminated tumor cells (DTC) in bone marrow at surgery identifies breast cancer patients (pts) with long-term risk of distant recurrence and breast cancer-specific death by Magbanua, MJM, Yau, C, Wolf, D, Lee, JS, Chattopadhyay, A, Scott, JH, Yoder, E, Hwang, S, Alvarado, M, Ewing, CA, Delson, AL, van't Veer, L, Esserman, L, Park, JW

“…Abstract We examined the prognostic impact of CTCs and DTCs detected at the time of definitive surgery in pts diagnosed with early breast cancer (EBC)…”
Get full text

Abstract PD2-01: Personalized serial circulating tumor DNA (ctDNA) analysis in high-risk early stage breast cancer patients to monitor and predict response to neoadjuvant therapy and outcome in the I-SPY 2 TRIAL by Magbanua, MJM, Brown-Swigart, L, Hirst, GL, Yau, C, Wolf, D, Ma, AA, Bergin, E, Venters, S, Sethi, H, Wu, H-T, Salari, R, Tin, T, Sawyer, S, Louie, M, Zimmermann, B, Lin, C-HJ, Keats, J, Liang, WS, Cuyugan, L, Enriquez, D, Tripathy, D, Chien, AJ, Forero, A, DeMichele, A, Liu, M, Delson, AL, Asare, S, Esserman, L, van't Veer, L

“…Abstract ctDNA analysis offers a non-invasive approach for monitoring response and resistance to treatment. Serial ctDNA testing during neoadjuvant therapy…”
Get full text

Abstract PD6-8: Prognostic value of disseminated tumor cells according to ER/PR and HER2 status in non-metastatic breast cancer by Lee, JS, Magbanua, MJM, Moore, AP, Esserman, LJ, Park, JW

“…Abstract Background: Disseminated tumor cells (DTCs) in the bone marrow from breast cancer patients have been reported as a prognostic factor. We evaluated…”
Get full text

Abstract P2-01-05: Parallel DNA and RNA profiling of EpCAM-positive cells in blood of metastatic breast cancer (MBC) patients confirm their malignant nature by Magbanua, MJM, Hauranieh, L, Sosa, EV, Pendyala, P, Scott, JH, Rugo, HS, Park, JW

“…Abstract Background: Molecular studies of EpCAM-positive cells found in the blood of cancer patients have been limited to immuno-enriched samples containing a…”
Get full text

Abstract PD04-10: Genome-Wide Copy Number Analysis of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients by Magbanua, MJM, Sosa, EV, Scott, JH, Pinkel, D, Rugo, HS, Park, JW

“…Abstract Background: Clinical studies have demonstrated the prognostic and predictive value of the number of CTCs in metastatic breast cancer. However, it is…”
Get full text